111 related articles for article (PubMed ID: 9484828)
21. Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
Oxley JD; Abbott CD; Gillatt DA; MacIver AG
Br J Urol; 1998 Jan; 81(1):109-15. PubMed ID: 9467486
[TBL] [Abstract][Full Text] [Related]
22. The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcome.
Ohlson N; Bergh A; Nygren K; Stattin P; Wikström P
Eur Urol; 2006 Apr; 49(4):675-83. PubMed ID: 16387414
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Wolf HK; Stöber C; Hohenfellner R; Leissner J
Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
[TBL] [Abstract][Full Text] [Related]
24. Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma.
Szende B; Romics I; Minik K; Szabó J; Torda I; Lovász S; Szomor L; Tóth L; Bély M; Kerényi T; Bartók K; Végh A
Prostate; 2001 Oct; 49(2):93-100. PubMed ID: 11582587
[TBL] [Abstract][Full Text] [Related]
25. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
26. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.
Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG
Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.
De Angelis PM; Stokke T; Thorstensen L; Lothe RA; Clausen OP
Mol Pathol; 1998 Oct; 51(5):254-61. PubMed ID: 10193519
[TBL] [Abstract][Full Text] [Related]
28. Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines.
Ng AY; Bales W; Veltri RW
Anal Quant Cytol Histol; 2000 Feb; 22(1):45-54. PubMed ID: 10696460
[TBL] [Abstract][Full Text] [Related]
29. Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival.
Stattin P; Damber JE; Karlberg L; Nordgren H; Bergh A
Urol Res; 1996; 24(5):257-64. PubMed ID: 8931289
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.
Shiina H; Igawa M; Shigeno K; Yamasaki Y; Urakami S; Yoneda T; Wada Y; Honda S; Nagasaki M
Oncology; 1999 Apr; 56(3):239-47. PubMed ID: 10202280
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected].
Beardsmore DM; Verbeke CS; Davies CL; Guillou PJ; Clark GW
J Gastrointest Surg; 2003 Jan; 7(1):77-86; discussion 86-7. PubMed ID: 12559188
[TBL] [Abstract][Full Text] [Related]
33. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation.
Ihling C; Szombathy T; Nampoothiri K; Haendeler J; Beyersdorf F; Uhl M; Zeiher AM; Schaefer HE
Heart; 1999 Sep; 82(3):286-93. PubMed ID: 10455077
[TBL] [Abstract][Full Text] [Related]
34. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
35. Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL.
Toms SA; Hercbergs A; Liu J; Kondo S; Haqqi T; Casey G; Iwasaki K; Barnett GH; Barna BP
J Neurosurg; 1998 May; 88(5):884-9. PubMed ID: 9576258
[TBL] [Abstract][Full Text] [Related]
36. Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer.
Matsumoto H; Wada T; Fukunaga K; Yoshihiro S; Matsuyama H; Naito K
Jpn J Clin Oncol; 2004 Mar; 34(3):124-30. PubMed ID: 15078907
[TBL] [Abstract][Full Text] [Related]
37. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.
Basolo F; Pollina L; Fontanini G; Fiore L; Pacini F; Baldanzi A
Br J Cancer; 1997; 75(4):537-41. PubMed ID: 9052406
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of apoptosis-related factors in lining epithelium of radicular cysts.
Suzuki T; Kumamoto H; Kunimori K; Ooya K
J Oral Pathol Med; 2005 Jan; 34(1):46-52. PubMed ID: 15610406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
